Literature DB >> 11507096

The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis.

H Higuchi1, S F Bronk, Y Takikawa, N Werneburg, R Takimoto, W El-Deiry, G J Gores.   

Abstract

Toxic bile salts induce hepatocyte apoptosis by both Fas-dependent and -independent mechanisms. In this study, we examined the cellular mechanisms responsible for Fas-independent, bile acid-mediated apoptosis. HuH-7 cells, which are known to be Fas deficient, were stably transfected with the sodium-dependent bile acid transporting polypeptide. The toxic bile acid glycochenodeoxycholate (GCDC)-induced apoptosis in these cells in a time- and concentration-dependent manner. Apoptosis and mitochondrial cytochrome c release were inhibited by transfection with dominant negative FADD, CrmA transfection, or treatment with the selective caspase 8 inhibitor IETD-CHO. These observations suggested the Fas-independent apoptosis was also death receptor mediated. Reverse transcriptase-polymerase chain reaction demonstrated tumor necrosis factor-R1, tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-R1/DR4, -R2/DR5, and TRAIL, but not tumor necrosis factor-alpha expression by these cells. GCDC treatment increased expression of TRAIL-R2/DR5 mRNA and protein 10-fold while expression of TRAIL-R1 was unchanged. Furthermore, aggregation of TRAIL-R2/DR5, but not TRAIL-R1/DR4 was observed following GCDC treatment of the cells. Induction of TRAIL-R2/DR5 expression and apoptosis by bile acids provides new insights into the mechanisms of hepatocyte apoptosis and the regulation of TRAIL-R2/DR5 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507096     DOI: 10.1074/jbc.M105300200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Fernando J Barreyro; Maria E Guicciardi; Yuko Akazawa; Karen Braley; Ruth W Craig; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

3.  Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.

Authors:  Astrid Kosters; Julio C Felix; Moreshwar S Desai; Saul J Karpen
Journal:  J Hepatol       Date:  2013-10-10       Impact factor: 25.083

4.  Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.

Authors:  Geum-Youn Gwak; Tae Gun Moon; Dong Ho Lee; Byung Chul Yoo
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

5.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

6.  Taurolithocholate-induced MRP2 retrieval involves MARCKS phosphorylation by protein kinase Cϵ in HUH-NTCP Cells.

Authors:  Christopher M Schonhoff; Cynthia R L Webster; M Sawkat Anwer
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

7.  Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis.

Authors:  Yan Liang; Zaixing Yang; Chang Li; Ye Zhu; Lingzhen Zhang; Renqian Zhong
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

8.  Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines.

Authors:  Bryson W Katona; Shrikant Anant; Douglas F Covey; William F Stenson
Journal:  J Biol Chem       Date:  2008-12-03       Impact factor: 5.157

9.  Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Steven F Bronk; Sophie Cazanave; Nathan W Werneburg; Justin L Mott; Patricia C Contreras; Gregory J Gores
Journal:  Hepatol Res       Date:  2009-07-13       Impact factor: 4.288

10.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.